Cargando…
Detection of carcinogen-induced bladder cancer by fluorocoxib A
BACKGROUND: Conventional cystoscopy can detect advanced stages of bladder cancer; however, it has limitations to detect bladder cancer at the early stages. Fluorocoxib A, a rhodamine-conjugated analog of indomethacin, is a novel fluorescent imaging agent that selectively targets cyclooxygenase-2 (CO...
Autores principales: | Bourn, Jennifer, Rathore, Kusum, Donnell, Robert, White, Wesley, Uddin, Md. Jashim, Marnett, Lawrence, Cekanova, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882158/ https://www.ncbi.nlm.nih.gov/pubmed/31775672 http://dx.doi.org/10.1186/s12885-019-6366-x |
Ejemplares similares
-
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019) -
Pharmacokinetic characterization of fluorocoxib D, a cyclooxygenase-2-targeted optical imaging agent for detection of cancer
por: Cekanova, Maria, et al.
Publicado: (2020) -
Development of Pluoronic nanoparticles of fluorocoxib A for endoscopic fluorescence imaging of colonic adenomas
por: Uddin, Md. Jashim, et al.
Publicado: (2023) -
Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A
por: Ra, Hyejun, et al.
Publicado: (2015) -
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer
por: Smolensky, Dmitriy, et al.
Publicado: (2016)